TrialNature medicine2024

Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial.

Jeffrey I Weitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.